Melex Technologies Inc. Launches Simple Life Science, a Life Science Company Supplying Peptide and Small Molecule API and Custom Synthesis to Laboratories
-
Mercedes-Benz cuts 2026 profit outlook on tough China market
-
Madushanka wrecks Pakistan as Sri Lanka press for final slot
-
Reparations calls follow Charles on tough Caribbean trip
-
Destructive Abhishek 113 leads India to series win over New Zealand
-
Jammu and Kashmir ministers resign before planned council expansion
-
Norway, Finland leaders hold 'frank and substantive' talk with Putin
-
Germany, EU, stable investment stops despite upheaval: Merz
-
Wall Street faces earnings and Fed tests after turbulent technology-led week
-
China brands drop Mbappe for 'offending national sentiments'
-
Ukraine, Russia say US-brokered truce holding in ravaged city
-
India orders evacuations as Cyclone Arnab looms
-
Police form SIT after vehicles in Rahul Gandhi convoy collide on expressway
-
Dutch broadcaster pulls out of Eurovision over Israel 'sensitivities'
-
Delhi grants minimum monthly pay and DA to about 4,000 MCD health workers
-
Critical coal inventories affect nearly half of India’s domestic power plants
-
Ather Energy shares climb 14% after quarterly profit and expansion plan
-
FCNR(B) deposit drive puts sharper margin pressure on private banks
-
Gold ETF flows turn negative after 13 weeks as bullion loses 4%
-
Noel Tata requests records of September 17 Tata Sons board meeting
-
Pakistan's last antique restorers give old treasures new life
-
Reparations calls to dog King Charles's tough Caribbean trip
-
India braces for Cyclone Arnab with evacuations
-
Global rates and foreign outflows remain key risks for Indian markets
-
Steel Strips Wheels gains 36% in two sessions on growth outlook
-
Neha Nagar says ₹3 crore can fund retirement with disciplined planning
-
Cavs edge T'Wolves in overtime despite superb Edwards
-
Vikas Satija says steady SIP flows shielded Indian equities from deeper losses
-
Prescott fires Cowboys to 38-21 win over plummeting Eagles
-
Brewers rout Rays to reach brink of World Series sweep
-
Kuwait padel chief hails national showing at Premier Padel Major
-
Mbappe dropped by Chinese brands for 'offending national sentiments'
-
Britain prepares constrained budget as debt and defence pressures mount
-
Kuwait exhibition presents Ukraine’s Islamic heritage and cultural ties
-
Valkyries beat Dream to reach brink of WNBA title
-
Tech firms track Wall St rally on mixed day for Asian markets
-
Benjamin Netanyahu: Israel's longest-serving PM fighting for survival
-
Jay-Z to perform at Super Bowl LXI halftime show: NFL
-
Kuwait receives invitation to 2026 UN Water Conference in Abu Dhabi
-
Climate-threatened Fijian utopia rejects calls to relocate
-
Arab World Institute president outlines plans for stronger Kuwait-France cultural links
-
Israel to give verdict on Netanyahu in pivotal election
-
Bolsonaro's party says it recognizes Lula's election win in Brazil
-
$1m bounties, dawn arrests: Trump presses voter fraud campaign
-
Meghan on TV menu for 'Junior MasterChef Australia'
-
Gasping for air: Borneo residents struggle as island burns
-
South Korea's chip boom fuels forecast-beating third-quarter growth
-
Doha exhibition charts a millennium of Chinese maritime ceramics trade
-
US-brokered truce begins in Ukraine city occupied by Russia
-
New Zealand ex-PM Ardern to teach leadership in Sydney
-
Qatar launches Fashion and Crafts Council to connect talent with global markets
Melex Technologies Inc. Launches Simple Life Science, a Life Science Company Supplying Peptide and Small Molecule API and Custom Synthesis to Laboratories
DELRAY BEACH, FL / ACCESS Newswire / October 27, 2026 / Melex Technologies Inc. today announced Simple Life Science (simplelifescience.com), a life science company serving laboratories and research organizations. Simple Life Science supplies peptide and small molecule active pharmaceutical ingredient (API), custom synthesis and analytical services. All peptides and API it sells are for laboratory research use only and are not for human or animal consumption.
Services
- API supply: peptide and small molecule API manufactured by Remetide, quoted to written specifications.
- Custom synthesis: projects follow a written scope covering design and feasibility, synthesis and purification, and analytical review (HPLC and MS), with documentation shipped with the material.
- Catalog materials: research materials with listed specifications, plus laboratory supplies.
Documentation
Simple Life Science publishes Certificates of Analysis (COAs) online, searchable by catalog item or lot. COAs are produced by Freedom Diagnostics, a third-party testing laboratory.
"Our goal is for researchers to be able to check the documentation behind every lot they order," said Alex Ehrenthal, co-founder of Simple Life Science with Melissa Ehrenthal.
About Simple Life Science
Simple Life Science (simplelifescience.com) is a life science company owned and operated by Melex Technologies Inc. It supplies peptide and small molecule API and custom synthesis services to laboratories and research organizations. Its products are not intended for human or animal consumption, or to diagnose, treat, cure or prevent any disease.
About Melex Technologies Inc.
Melex Technologies Inc., based in Delray Beach, Florida, operates the Simple Peptide, Alpha Omega Peptide, Simple Life Science and Simple Cosmetics brands.
Media contact
Alex Ehrenthal | [email protected] | 561-501-1570
SOURCE: Simple Cosmetics LLC
View the original press release on ACCESS Newswire
P.Smith--AT
